Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SCNN1A | P37088 | 4/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ACSS2 | Q9NR19 | 4/20 | 0.33 |
| ▸ | CTSA | P10619 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2018304 | 0.86 | HTT (0.40) | HTTSCNN1ATSHRTP53KMT2A | |
| SCHEMBL2018438 | 0.83 | SCNN1A (0.44) | HTTSCNN1ATP53ACSS2 | |
| Iodide SCHEMBL2018152 | 0.83 | SCNN1A (0.40) | SCNN1A | |
| SCHEMBL12635701 | 0.82 | ACSS2 (0.49) | HTTSCNN1AACSS2 | |
| SCHEMBL2015541 | 0.82 | HTT (0.46) | HTTTSHRACSS2 | |
| SCHEMBL2040435 | 0.82 | HTT (0.45) | HTTTSHRTP53MEN1KMT2A | |
| SCHEMBL2020165 | 0.82 | ACSS2 (0.46) | HTTSCNN1ATSHRMEN1KMT2A | |
| SCHEMBL2014823 | 0.81 | HTT (0.45) | HTTSCNN1ATSHRTP53MEN1 | |
| SCHEMBL2016331 | 0.81 | HTT (0.52) | HTTSCNN1ATSHRTP53MEN1 | |
| SCHEMBL12636338 | 0.81 | SCNN1A (0.40) | HTTSCNN1ATSHRTP53KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011079087-A1 | ENAC BLOCKERS | GLAXO GROUP LIMITED (GB) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011079087-A1 | ENAC BLOCKERS | GLAXO GROUP LIMITED (GB) | 2011-06-30 | — | — | WO | disclosed |